RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex

Michael A. Estrella, Fang Ting Kuo, Scott Bailey

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

The CRISPR (clustered regularly interspaced short palindromic repeat) system is an RNA-guided immune system that protects prokaryotes from invading genetic elements. This system represents an inheritable and adaptable immune system that is mediated by multisubunit effector complexes. In the Type III-B system, the Cmr effector complex has been found to cleave ssRNA in vitro. However, in vivo, it has been implicated in transcription-dependent DNA targeting. We show here that the Cmr complex from Thermotoga maritimacan cleave an ssRNA target that is complementary to the CRISPR RNA. We also show that binding of a complementary ssRNA target activates an ssDNA-specific nuclease activity in the histidine–aspartate (HD) domain of the Cmr2 subunit of the complex. These data suggest a mechanism for transcription-coupled DNA targeting by the Cmr complex and provide a unifying mechanism for all Type III systems.

Original languageEnglish (US)
Pages (from-to)460-470
Number of pages11
JournalGenes and Development
Volume30
Issue number4
DOIs
StatePublished - Feb 15 2016

Keywords

  • CMR
  • CRISPR–Cas
  • Nuclease
  • RAMP
  • RNA

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Fingerprint

Dive into the research topics of 'RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex'. Together they form a unique fingerprint.

Cite this